Managed Care Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biophan Technologies, Inc.
Report gives "buy" rating to nanotechnology, biomedical device maker
October 9th, 2005
Biophan Technologies, Inc., (BIPH) has received an unqualified "buy" rating in an independent, third-party research report written by a leading German analyst, Midas Research GmbH. The report was paid for by Biophan. The report, entitled, "Enabling the Evolution of Medical Devices," provides a comprehensive, 19-page corporate overview and analysis of Biophan, accompanied by graphics and illustrations. It discusses the company's wide range of innovative biomedical solutions and potential for market success, as well as a recent landmark technology licensing agreement with Boston Scientific, a major strategic partner. The report...
Source: Managed Care Law Weekly (2005-10-09)
|
